Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panaccione

Showing results (371-380 of 652) with videos related to

Pageof 66
Sort By:
Gastroenterology|February 12, 2014
Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitisRemo Panaccione, Subrata Ghosh, Stephen Middleton, et al.
Inflammatory Bowel Diseases|August 21, 2023
The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative ColitisSimon Travis, Alison Potts Bleakman, Marla C Dubinsky, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 28, 2017
Asthma Is Associated With Subsequent Development of Inflammatory Bowel Disease: A Population-based Case-Control StudyM Ellen Kuenzig, Cheryl Barnabe, Cynthia H Seow, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2023
Meta-analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control armPatrick Hamilton, Katherine Buhler, John K MacDonald, et al.
Inflammatory Bowel Diseases|May 20, 2015
Briakinumab for treatment of Crohn's disease: results of a randomized trialRemo Panaccione, William J Sandborn, Glenn L Gordon, et al.
Nanotechnology|October 25, 2012
Growth of ultrathin epitaxial Fe/MgO spin injector on (0, 0, 1) (Ga, Mn)AsP Torelli, M Sperl, R Ciancio, et al.
Journal of Crohn'S & Colitis|April 29, 2020
A Diversified Dietary Pattern Is Associated With a Balanced Gut Microbial Composition of Faecalibacterium and Escherichia/Shigella in Patients With Crohn's Disease in RemissionZhengxiao Zhang, Lorian Taylor, Nusrat Shommu, et al.
Gastroenterology|October 18, 2011
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic reviewNatalie A Molodecky, Ing Shian Soon, Doreen M Rabi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 29, 2020
Assessing National Trends and Disparities in Ambulatory, Emergency Department, and Inpatient Visits for Inflammatory Bowel Disease in the United States (2005-2016)Christopher Ma, Matthew K Smith, Leonardo Guizzetti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2019
Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug DevelopmentWalter Reinisch, Klaus Gottlieb, Jean-Frederic Colombel, et al.
Pageof 66

Showing results (371-380 of 652) with videos related to

Sort By:
Pageof 66
Gastroenterology|February 12, 2014
Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitisRemo Panaccione, Subrata Ghosh, Stephen Middleton, et al.
Inflammatory Bowel Diseases|August 21, 2023
The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative ColitisSimon Travis, Alison Potts Bleakman, Marla C Dubinsky, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 28, 2017
Asthma Is Associated With Subsequent Development of Inflammatory Bowel Disease: A Population-based Case-Control StudyM Ellen Kuenzig, Cheryl Barnabe, Cynthia H Seow, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2023
Meta-analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control armPatrick Hamilton, Katherine Buhler, John K MacDonald, et al.
Inflammatory Bowel Diseases|May 20, 2015
Briakinumab for treatment of Crohn's disease: results of a randomized trialRemo Panaccione, William J Sandborn, Glenn L Gordon, et al.
Nanotechnology|October 25, 2012
Growth of ultrathin epitaxial Fe/MgO spin injector on (0, 0, 1) (Ga, Mn)AsP Torelli, M Sperl, R Ciancio, et al.
Journal of Crohn'S & Colitis|April 29, 2020
A Diversified Dietary Pattern Is Associated With a Balanced Gut Microbial Composition of Faecalibacterium and Escherichia/Shigella in Patients With Crohn's Disease in RemissionZhengxiao Zhang, Lorian Taylor, Nusrat Shommu, et al.
Gastroenterology|October 18, 2011
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic reviewNatalie A Molodecky, Ing Shian Soon, Doreen M Rabi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 29, 2020
Assessing National Trends and Disparities in Ambulatory, Emergency Department, and Inpatient Visits for Inflammatory Bowel Disease in the United States (2005-2016)Christopher Ma, Matthew K Smith, Leonardo Guizzetti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2019
Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug DevelopmentWalter Reinisch, Klaus Gottlieb, Jean-Frederic Colombel, et al.
Pageof 66